Inspire Medical Systems（INSP）今日夜盘股价大幅下挫10.85%，引发市场关注。
消息面上，多家华尔街知名投行于同日下调了该公司的目标价。具体来看，杰富瑞将目标价从81美元下调至66美元，摩根大通将目标价从118美元下调至67美元，Leerink Partners将目标价从127美元下调至78美元，加拿大皇家银行则将目标价从90美元下调至68美元。
分析师集中下调目标价通常反映了对公司未来业绩或行业前景的谨慎看法，这一系列负面评级调整被认为是导致该股夜盘遭遇抛售、股价显著下跌的主要原因。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.